Amgen Settles Aranesp Misbranding Cases With Guilty Plea And Payment Of $762 Million
By:
A federal judge has approved a $762 million settlement agreement with Biotechnology giant Amgen to resolve a number of criminal and civil cases stemming from the sale of its anemia drug Aranesp and...
read more